New benzimidazole‐oxadiazole derivatives as potent VEGFR‐2 inhibitors: Synthesis, anticancer evaluation, and docking study.

MLA

Acar Çevik, Ulviye, et al. “New Benzimidazole‐oxadiazole Derivatives as Potent VEGFR‐2 Inhibitors: Synthesis, Anticancer Evaluation, and Docking Study.” Drug Development Research, vol. 85, no. 4, June 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1002/ddr.22218.

APA

Acar Çevik, U., Celik, I., Görgülü, Ş., Şahin Inan, Z. D., Bostancı, H. E., Özkay, Y., & Kaplacıklı, Z. A. (2024). New benzimidazole‐oxadiazole derivatives as potent VEGFR‐2 inhibitors: Synthesis, anticancer evaluation, and docking study. Drug Development Research, 85(4), 1–10. https://doi.org/10.1002/ddr.22218

Chicago

Acar Çevik, Ulviye, Ismail Celik, Şennur Görgülü, Zeynep Deniz Şahin Inan, Hayrani Eren Bostancı, Yusuf Özkay, and Zafer Asım Kaplacıklı. 2024. “New Benzimidazole‐oxadiazole Derivatives as Potent VEGFR‐2 Inhibitors: Synthesis, Anticancer Evaluation, and Docking Study.” Drug Development Research 85 (4): 1–10. doi:10.1002/ddr.22218.